(Total Views: 14)
Posted On: 08/26/2025 2:31:46 PM
Post# of 38902

$ADTX News Aditxt’s Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030 https://finance.yahoo.com/news/aditxt-subsidi...00900.html

